Kimberly Nagamine

Kimberly Nagamine

Auto-generated profile, based on publicly available information

Kimberly Nagamine

Department of Obstetrics and Gynecology, University of Hawaii, Kapiolani Medical Center for Women and Children, 1319 Punahou Street, Room 824, Honolulu, HI 96826, United States

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
KNKimberly Nagamine
Kimberly Nagamine
JKJordan Kondo
Jordan Kondo
RKRicky Kaneshiro
Ricky Kaneshiro
PTPamela Tauchi-Nishi
Pamela Tauchi-Nishi
KTKeith Terada
Keith Terada
Nagamine K, et al. J Gynecol Oncol. 2017 Jan;28(4):e40. https://doi.org/10.3802/jgo.2017.28.e40

1 August 2017 in Gynecologic Oncology Reports
Verified
Journal Article
Open access
KNKimberly Nagamine
Kimberly Nagamine
SISophia Iwasaki
Sophia Iwasaki
DSDavid Shimizu
David Shimizu
PTPamela Tauchi-Nishi
Pamela Tauchi-Nishi
KTKeith Terada
Keith Terada
Placental site trophoblastic tumor (PSTT) is a rare form of gestational trophoblastic neoplasia (GTN). It most commonly occurs after a delivery but may arise after any type of pregnancy. PSTT arises after neoplastic transformation of intermediate trophoblastic cells. The most commonly reported symptoms are abnormal bleeding or amenorrhea. Due to the rarity of this disease, evidence on prognostic factors as well as optimal treatment is limited. While treatment for early-stage disease is usually limited to surgery, multimodal treatment with chemotherapy and surgery may be important for metastatic disease. Metastatic disease may be associated with minimal elevations of human chorionic gonadotropin (hCG). Here we present an unusual case of a patient with PSTT and an isolated breast metastasis who was successfully treated with surgical resection and single-agent chemotherapy.